Can Hormonal Rx for Prostate Cancer Raise Dementia Risk?

THURSDAY, Oct. 13, 2016 — The risk of dementia might be doubled for prostate cancer patients who are treated with testosterone-lowering drugs, a new study suggests.
Men who underwent androgen-deprivation therapy (ADT) had close to an 8 percent risk…
Source: Topamax